The fabrication of electrochemical biosensors without any binder or enzymes is in high demand in the clinical diagnostic and industrial sectors. This work presents the development of hydrogen-substituted graphdiyne encapsulated Cu2O nanowires (Cu2O NWs@ HsGDY) hybrid electrode, directly grown on Cu foils. The sp and sp2 hybridization of HsGDY is confirmed by Raman and X-ray photoelectron spectroscopy, and the HsGDY encapsulation over Cu2O NWs is observed in transmission electron microscope images. The fabricated binder-free, nonenzymatic electrode exhibits the highest sensitivity of 584.2 μA·cm2·μM–1 (Cu2O NWs@HsGDY-1 h), the lowest detection limits of 0.035 μM (Cu2O NWs@HsGDY-6 h) and a linear detection range of 0.5–2500 μM. The Cu2O NWs@HsGDY-6 h electrode demonstrates 70 days of stability (82%) and excellent reproducibility (RSD = 1.97%) compared to other hybrid electrodes. The improved glucose sensing performance and stability is a combined effect of semiconducting nature and catalytic ability are attributed to Cu2O NWs@HsGDY hybrid electrodes. The successful glucose detection in actual food samples indicates the practical applicability of the Cu2O NWs@HsGDY sensor.
No takes yet. Share an insight, caveat, or question.
Jeganathan et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: